Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15565467 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Treatment Strategies for Children With Smith-Magenis Syndrome
Conditions: Developmental Delay Disorders;   Chromosome Deletion;   Mental Retardation;   Sleep Disorders, Circadian Rhythm;   Self Injurious Behavior
Interventions: Drug: dTR Melatonin (NIH CC PDS);   Device: Phototherapy (Bright Light);   Drug: Melatonin CR

Indicates status has not been verified in more than two years